OncoZenge AB (publ) (STO:ONCOZ)
Sweden
· Delayed Price · Currency is SEK 5.74
-0.61 (-9.61%)
At close: Mar 9, 2026
OncoZenge AB Revenue
In the year 2025, OncoZenge AB had annual revenue of 2.78M SEK with 278,300.00% growth. OncoZenge AB had revenue of 1,000.00 in the quarter ending December 31, 2025.
Revenue
2.78M
Revenue Growth
+278,300.00%
P/S Ratio
28.96
Revenue / Employee
2.78M
Employees
1
Market Cap
80.64M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Scandinavian ChemoTech AB | 12.29M |
| Spago Nanomedical AB | 4.82M |
| Biosergen AB | 2.09M |
| Biovica International AB | 9.89M |
| Alligator Bioscience AB | 4.42M |
| Alzinova AB | 26.12M |
| Xbrane Biopharma AB | 152.35M |
| Pila Pharma AB | 1.13M |